Are There Therapeutic Strategies Targeting Metalloproteinases?
Given their role in disease, several therapeutic strategies have been developed to target metalloproteinases. These include small molecule inhibitors, monoclonal antibodies, and gene therapy approaches aimed at modulating their activity. However, challenges remain in achieving specificity and minimizing side effects, underscoring the need for continued research.
